Wegovy and hair loss: what's actually happening to your hair

Is hair loss actually a side effect of Wegovy — or is something else going on?

This is probably the question our prescribers hear most often once patients are a few months into treatment. The honest answer is: it is probably both, and untangling them matters.

Semaglutide does appear in the reported side effects for Wegovy on the NHS medicines pages, so it would be wrong to say the medicine is irrelevant. But the clinical picture is more nuanced. Hair has a growth cycle with an active phase (anagen) and a resting phase (telogen), after which hairs shed and new ones replace them. Any significant physical stressor (surgery, illness, pregnancy, or abrupt weight loss) can push a larger-than-normal proportion of follicles into the resting phase simultaneously. Two to four months later, those follicles shed together, which looks dramatic but is not actually follicle damage.

When someone loses weight quickly, as many people do in the first months of Wegovy treatment, the body reads the caloric deficit as physiological stress. That stress, not the medicine per se, is the dominant driver in most reported cases. The medicine creates the conditions; the weight loss itself is the more direct trigger. Distinguishing between the two is less important in practice than making sure nutrition is adequate, because a protein-poor diet during rapid weight loss amplifies the effect considerably.

The NHS semaglutide medicines page lists hair loss as an uncommon side effect, which means it occurs in fewer than 1 in 100 people in clinical data. Uncommon does not mean trivial if you are the person experiencing it, but it does mean the majority of people completing treatment never notice significant shedding at all.

Why does rapid weight loss affect the hair cycle?

The hair follicle is a surprisingly metabolically demanding structure. It needs a steady supply of protein, iron, zinc, and B vitamins to cycle normally. When calorie intake drops sharply, the body prioritises organs and tissues it considers more urgent, and the follicle slips down the queue. This is not a flaw in how semaglutide works; it is a known consequence of any rapid weight-reduction programme, whether medication-assisted or not.

People who have undergone bariatric surgery report the same pattern, significant shedding around three to four months post-procedure, followed by stabilisation and regrowth as the body adapts. The parallel is useful because it confirms that the mechanism is metabolic, not pharmacological.

A few practical things are known to help. Keeping protein intake adequate (rather than cutting it to reduce calories further) appears to be the most consistently cited protective factor. Staying hydrated, avoiding aggressive crash-restriction on top of the appetite reduction the medicine already produces, and taking a broad-spectrum multivitamin during active weight loss are all reasonable steps. None of these require a prescription; your GP or a registered dietitian can give specific guidance tailored to your situation. A detailed look at how people manage hair shedding on Wegovy covers practical approaches in more depth.

If you are also experiencing fatigue, feeling cold, or other symptoms alongside shedding, a GP can check thyroid function and iron stores, both of which are unrelated to semaglutide but can coincide with it.

Will the hair grow back, and how long does it take?

For telogen effluvium specifically, the evidence is reassuring. Because the follicle itself is not damaged (it has simply entered a resting phase earlier than usual) new growth typically begins once the physiological stress resolves. In practice, most people notice regrowth within three to six months of the shedding peak, though it can take up to a year for density to fully return.

The shedding usually peaks before it improves. The point at which someone notices the most hair on the shower floor is often just before the cycle tips back. That pattern is documented across all forms of telogen effluvium, not just weight-loss-related cases. A common misconception is that continuing the medicine will make things progressively worse, in fact, once the body adapts to the new metabolic baseline, the cycle tends to normalise. Stopping treatment solely because of hair shedding is a decision worth discussing with your prescriber before acting on it, particularly if the underlying weight-related health conditions are significant.

If you want a more detailed breakdown of what the evidence says about regrowth and timelines, the page on whether hair loss from Wegovy grows back goes through the data directly. And if you are still weighing up whether any of this changes your decision about treatment, you can find a fuller picture of how semaglutide affects hair before reading about what Wegovy does and does not do to hair thickness might help you feel more grounded in the decision.

Wegovy is a prescription-only medicine. Any concerns about ongoing shedding, or questions about whether your current treatment plan is the right one, belong in a conversation with your prescriber, not resolved by stopping or changing doses on your own. If you have not yet started treatment and want to understand more about eligibility and the clinical review process, our consultation page sets out how it works.